Last Updated: May 20, 2026

CLINICAL TRIALS PROFILE FOR TECARTUS

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for TECARTUS

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT03642626 ↗	MT2017-45: CAR-T Cell Therapy for Heme Malignancies	Recruiting	Masonic Cancer Center, University of Minnesota		2018-12-18	This is a phase II study of FDA-approved CAR-T products for patients with hematologic malignancies. Patients will be assigned to Arm A and B based on age and diagnosis. Overall remission rate, safety events and other endpoints will be calculated for Arm A and B separately.
NCT05993949 ↗	Study of Brexucabtagene Autoleucel Plus Dasatinib in Adults With Acute Lymphoblastic Leukemia	Recruiting	Kite Pharma	Phase 1	2023-10-02	To assess the feasibility of oral dasatinib pulses (3 consecutive days per week) during the first month following infusion of brexucabtagene autoleucel (Tecartus) in adults with relapsed or refractory B-cell acute lymphoblastic leukemia.
NCT05993949 ↗	Study of Brexucabtagene Autoleucel Plus Dasatinib in Adults With Acute Lymphoblastic Leukemia	Recruiting	Stanford University	Phase 1	2023-10-02	To assess the feasibility of oral dasatinib pulses (3 consecutive days per week) during the first month following infusion of brexucabtagene autoleucel (Tecartus) in adults with relapsed or refractory B-cell acute lymphoblastic leukemia.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for TECARTUS

Condition Name

Chart
Table

Condition Name for TECARTUS
Intervention	Trials
Acute Lymphoblastic Leukemia	2
B-Cell Lymphoblastic Leukemia	1
Hematopoietic and Lymphatic System Neoplasm	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for TECARTUS
Intervention	Trials
Leukemia, Lymphoid	3
Precursor Cell Lymphoblastic Leukemia-Lymphoma	3
Leukemia	2
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for TECARTUS

Trials by Country

Map
Table

Trials by Country for TECARTUS
Location	Trials
United States	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for TECARTUS
Location	Trials
Oregon	1
Florida	1
California	1
Minnesota	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for TECARTUS

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for TECARTUS
Clinical Trial Phase	Trials
PHASE2	1
Phase 2	1
Phase 1	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for TECARTUS
Clinical Trial Phase	Trials
Recruiting	3
NOT_YET_RECRUITING	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TECARTUS

Sponsor Name

Chart
Table

Sponsor Name for TECARTUS
Sponsor	Trials
Masonic Cancer Center, University of Minnesota	1
Kite Pharma	1
Stanford University	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for TECARTUS
Sponsor	Trials
Other	7
Industry	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.